Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The pharmacology of aldose reductase inhibitors.

× No keyword cloud information.

28 in total

1. The polyol pathway in retinal microangiopathy.

Authors: W G Robison; J H Kinoshita; P F Kador
Journal: Drugs Date: 1986 Impact factor: 9.546

2. Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors.

Authors: P F Kador; J H Kinoshita; D R Brittain; D J Mirrlees; C M Sennitt; D Stribling
Journal: Biochem J Date: 1986-11-15 Impact factor: 3.857

3. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.

Authors: H P Hammes; A Weiss; D Führer; H J Krämer; C Papavassilis; F Grimminger
Journal: Diabetologia Date: 1996-03 Impact factor: 10.122

4. Investigation of the role of a conserved glycine motif in the Saccharomyces cerevisiae xylose reductase.

Authors: Byron C H Chu; Hung Lee
Journal: Curr Microbiol Date: 2006-06-26 Impact factor: 2.188

5. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.

Authors: L B Dahlin; D R Archer; W G McLean
Journal: Diabetologia Date: 1987-06 Impact factor: 10.122

6. Caloric restriction counteracts age-related changes in the activities of sorbitol metabolizing enzymes from mouse liver.

Authors: Kevork Hagopian; Jon J Ramsey; Richard Weindruch
Journal: Biogerontology Date: 2008-10-25 Impact factor: 4.277

7. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.

Authors: A Y Lee; S K Chung; S S Chung
Journal: Proc Natl Acad Sci U S A Date: 1995-03-28 Impact factor: 11.205

8. Structure of xylose reductase bound to NAD+ and the basis for single and dual co-substrate specificity in family 2 aldo-keto reductases.

Authors: Kathryn L Kavanagh; Mario Klimacek; Bernd Nidetzky; David K Wilson
Journal: Biochem J Date: 2003-07-15 Impact factor: 3.857

9. Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues.

Authors: Kun-Che Chang; Brian Laffin; Jessica Ponder; Anna Enzsöly; János Németh; Daniel V LaBarbera; J Mark Petrash
Journal: Chem Biol Interact Date: 2012-12-15 Impact factor: 5.192

10. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Authors: H P Hammes; S Martin; K Federlin; K Geisen; M Brownlee
Journal: Proc Natl Acad Sci U S A Date: 1991-12-15 Impact factor: 11.205